These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9456285)

  • 1. Cardiac and vascular responses after monocrotaline-induced hypertrophy in rats.
    Brown L; Miller J; Dagger A; Sernia C
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):108-15. PubMed ID: 9456285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
    Dhein S; Giessler C; Heinroth-Hoffmann I; Leineweber K; Seyfarth T; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):87-95. PubMed ID: 11819025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
    Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K
    Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure.
    Leineweber K; Brandt K; Wludyka B; Beilfuss A; Pönicke K; Heinroth-Hoffmann I; Brodde OE
    Circ Res; 2002 Nov; 91(11):1056-62. PubMed ID: 12456492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
    Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
    Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure.
    Vescovo G; Jones SM; Harding SE; Poole-Wilson PA
    J Mol Cell Cardiol; 1989 Oct; 21(10):1047-61. PubMed ID: 2555526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular changes in the beta-adrenoceptor-adenylate cyclase system of the rat heart with the progress of monocrotaline-induced right ventricular hypertrophy.
    Yoshie H; Tobise K; Onodera S
    Jpn Circ J; 1994 Nov; 58(11):855-65. PubMed ID: 7807685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure.
    Atkins FL; Bing OH; DiMauro PG; Conrad CH; Robinson KG; Brooks WW
    Hypertension; 1995 Jul; 26(1):78-82. PubMed ID: 7607736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
    Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).
    Brunner F; Wölkart G; Haleen S
    J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
    Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
    Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of right ventricular hypertrophy in neonatal guinea pigs by monocrotaline.
    Tatebe S; Miyamura H; Sugawara M; Watanabe H; Eguchi S
    Jpn Circ J; 1996 Aug; 60(8):604-8. PubMed ID: 8889663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
    Kato T; Nasu T; Sonoda H; Ito KM; Ikeda M; Ito K
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):18-23. PubMed ID: 18209564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
    Kögler H; Hartmann O; Leineweber K; Nguyen van P; Schott P; Brodde OE; Hasenfuss G
    Circ Res; 2003 Aug; 93(3):230-7. PubMed ID: 12842921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
    Jasmin JF; Cernacek P; Dupuis J
    Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocrotaline-induced pulmonary hypertension in Wistar rats.
    Rey M; Hess P; Clozel M
    Curr Protoc Pharmacol; 2009 Sep; Chapter 5():Unit 5.56. PubMed ID: 22294402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.